Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Soldano Ferrone

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Living Beings

Physiology

Anatomy

Concepts & Ideas

Molecular Sequence Data

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
zu Horste Gerd Meyer; Heidenreich Holger; Lehmann Helmar C; Ferrone Soldano; Hartung Hans-Peter; Wiendl Heinz; Kieseier Bernd C
Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies.
López-Albaitero Andrés; Lee Steve C; Morgan Sarah; Grandis Jennifer R; Gooding William E; Ferrone Soldano; Ferris Robert L
Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells.
Lin Jingrong; Takata Minoru; Murata Hiroshi; Goto Yasufumi; Kido Kenji; Ferrone Soldano; Saida Toshiaki
Polyclonality of BRAF mutations in acquired melanocytic nevi.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Soldano Ferrone (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: zu Horste Gerd Meyer; Heidenreich Holger; Lehmann Helmar C; Ferrone Soldano; Hartung Hans-Peter; Wiendl Heinz; Kieseier Bernd C
Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies.
Glia 2010;58(1):80-92.
2009: López-Albaitero Andrés; Lee Steve C; Morgan Sarah; Grandis Jennifer R; Gooding William E; Ferrone Soldano; Ferris Robert L
Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells.
Cancer immunology, immunotherapy : CII 2009;58(11):1853-64.
2009: Lin Jingrong; Takata Minoru; Murata Hiroshi; Goto Yasufumi; Kido Kenji; Ferrone Soldano; Saida Toshiaki
Polyclonality of BRAF mutations in acquired melanocytic nevi.
Journal of the National Cancer Institute 2009;101(20):1423-7.
2009: Yang Jianbo; Price Matthew A; Li Gui Yuan; Bar-Eli Menashe; Salgia Ravi; Jagedeeswaran Ramasamy; Carlson Jennifer H; Ferrone Soldano; Turley Eva A; McCarthy James B
Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition.
Cancer research 2009;69(19):7538-47.
2009: Paul Asit K; Ciesielski Michael J; Sajjad Munawwar; Wang Xinhui; Ferrone Soldano; Abdel-Nabi Hani; Fenstermaker Robert A
Expression of HMP/AN2, a melanoma associated antigen, in murine cerebral gliomas: potential for radioimmunotargeting.
Journal of neuro-oncology 2009;94(1):21-30.
2009: Mine Takashi; Matsueda Satoko; Li Yufeng; Tokumitsu Hiroshi; Gao Hui; Danes Cristopher; Wong Kwong-Kwok; Wang Xinhui; Ferrone Soldano; Ioannides Constantin G
Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells.
Cancer immunology, immunotherapy : CII 2009;58(8):1185-94.
2009: Sconocchia Giuseppe; Spagnoli Giulio Cesare; Del Principe Domenico; Ferrone Soldano; Anselmi Maurizio; Wongsena Wachanan; Cervelli Valerio; Schultz-Thater Elke; Wyler Stephen; Carafa Vincenza; Moch Holger; Terracciano Luigi; Tornillo Luigi
Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction.
Neoplasia (New York, N.Y.) 2009;11(7):662-71.
2009: López-Albaitero Andrés; Mailliard Robbie; Hackman Trevor; Andrade Filho Pedro A; Wang Xinhui; Gooding William; Ferrone Soldano; Kalinski Pawel; Ferris Robert L
Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting function.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(5):465-73.
2009: Shen Yuqing; Xia Mei; Zhang Jianqiong; Xu Lianhong; Yang Jin; Chen Aiqin; Miao Fengqin; Ferrone Soldano; Xie Wei
IRF-1 and p65 mediate upregulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cells.
Molecular immunology 2009;46(10):2045-53.
2009: Verheyden Sonja; Ferrone Soldano; Mulder Arend; Claas Frans H; Schots Rik; De Moerloose Barbara; Benoit Yves; Demanet Christian
Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
Cancer immunology, immunotherapy : CII 2009;58(6):855-65.
2009: Fourcade Julien; Kudela Pavol; Sun Zhaojun; Shen Hongmei; Land Stephanie R; Lenzner Diana; Guillaume Philippe; Luescher Immanuel F; Sander Cindy; Ferrone Soldano; Kirkwood John M; Zarour Hassane M
PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(9):5240-9.
2009: Lakshmikanth Tadepally; Burke Shannon; Ali Talib Hassan; Kimpfler Silvia; Ursini Francesco; Ruggeri Loredana; Capanni Marusca; Umansky Viktor; Paschen Annette; Sucker Antje; Pende Daniela; Groh Veronika; Biassoni Roberto; Höglund Petter; Kato Masashi; Shibuya Kazuko; Schadendorf Dirk; Anichini Andrea; Ferrone Soldano; Velardi Andrea; Kärre Klas; Shibuya Akira; Carbone Ennio; Colucci Francesco
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.
The Journal of clinical investigation 2009;119(5):1251-63.
2009: La Rocca Rosanna; Fulciniti Mariateresa; Lakshmikanth Tadepally; Mesuraca Maria; Ali Talib Hassan; Mazzei Valerio; Amodio Nicola; Catalano Lucio; Rotoli Bruno; Ouerfelli Ouathek; Grieco Michele; Gulletta Elio; Bond Heather M; Morrone Giovanni; Ferrone Soldano; Carbone Ennio
Early hematopoietic zinc finger protein prevents tumor cell recognition by natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(8):4529-37.
2009: Santisteban Marta; Reiman Jennifer M; Asiedu Michael K; Behrens Marshall D; Nassar Aziza; Kalli Kimberly R; Haluska Paul; Ingle James N; Hartmann Lynn C; Manjili Masoud H; Radisky Derek C; Ferrone Soldano; Knutson Keith L
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.
Cancer research 2009;69(7):2887-95.
2009: Kitago Minoru; Koyanagi Kazuo; Nakamura Takeshi; Goto Yasufumi; Faries Mark; O'Day Steven J; Morton Donald L; Ferrone Soldano; Hoon Dave S B
mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads.
Clinical chemistry 2009;55(4):757-64.
2009: Tourkova Irina L; Shurin Galina V; Ferrone Soldano; Shurin Michael R
Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells.
Cancer immunology, immunotherapy : CII 2009;58(4):567-74.
2009: Weiner Louis M; Dhodapkar Madhav V; Ferrone Soldano
Monoclonal antibodies for cancer immunotherapy.
Lancet 2009;373(9668):1033-40.
2009: Hsieh Chin-Hsuan; Hsu Ya-Jan; Chang Chien-Chung; Liu Hsin-Chun; Chuang Kun-Lung; Chuang Cheng-Keng; Pang See-Tong; Hasumi Kenichiro; Ferrone Soldano; Liao Shuen-Kuei
Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding beta2-microglobulin genes.
Cancer immunology, immunotherapy : CII 2009;58(3):395-408.
2009: Drake Allison S; Brady Michael T; Wang Xin Hui; Sait Sheila J N; Earp Justin C; Ghoshal Gupta Sampa; Ferrone Soldano; Wang Eunice S; Wetzler Meir
Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies.
Cancer immunology, immunotherapy : CII 2009;58(3):415-27.
2009: Schwab Joseph H; Boland Patrick J; Agaram Narasimhan P; Socci Nicholas D; Guo Tianhua; O'Toole Gary C; Wang Xinhui; Ostroumov Elena; Hunter Christopher J; Block Joel A; Doty Stephen; Ferrone Soldano; Healey John H; Antonescu Cristina R
Chordoma and chondrosarcoma gene profile: implications for immunotherapy.
Cancer immunology, immunotherapy : CII 2009;58(3):339-49.
2009: Tosello Valeria; Zamarchi Rita; Merlo Anna; Gorza Margherita; Piovan Erich; Mandruzzato Susanna; Bronte Vincenzo; Wang Xinhui; Ferrone Soldano; Amadori Alberto; Zanovello Paola
Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4.
European journal of immunology 2009;39(1):56-66.
2009: Vujanovic Lazar; Whiteside Theresa L; Potter Douglas M; Chu Jessica; Ferrone Soldano; Butterfield Lisa H
Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus.
Cancer immunology, immunotherapy : CII 2009;58(1):121-33.
2008: Seliger Barbara; Marincola Francesco M; Ferrone Soldano; Abken Hinrich
The complex role of B7 molecules in tumor immunology.
Trends in molecular medicine 2008;14(12):550-9.
2008: Goto Yasufumi; Arigami Takaaki; Kitago Minoru; Nguyen Sandy L; Narita Norihiko; Ferrone Soldano; Morton Donald L; Irie Reiko F; Hoon Dave S B
Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors.
Molecular cancer therapeutics 2008;7(11):3642-53.
2008: Maciag Paulo Cesar; Seavey Matthew M; Pan Zhen-Kun; Ferrone Soldano; Paterson Yvonne
Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.
Cancer research 2008;68(19):8066-75.
2008: Wondimu Assefa; Zhang Tianqian; Kieber-Emmons Thomas; Gimotty Phyllis; Sproesser Katrin; Somasundaram Rajasekharan; Ferrone Soldano; Tsao Chun-Yen; Herlyn Dorothee
Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice.
Cancer immunology, immunotherapy : CII 2008;57(7):1079-89.
2008: Goto Yasufumi; Ferrone Soldano; Arigami Takaaki; Kitago Minoru; Tanemura Atsushi; Sunami Eiji; Nguyen Sandy L; Turner Roderick R; Morton Donald L; Hoon Dave S B
Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3401-7.
2008: Han Liz Y; Fletcher Mavis S; Urbauer Diana L; Mueller Peter; Landen Charles N; Kamat Aparna A; Lin Yvonne G; Merritt William M; Spannuth Whitney A; Deavers Michael T; De Geest Koen; Gershenson David M; Lutgendorf Susan K; Ferrone Soldano; Sood Anil K
HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3372-9.
2008: Morandi Fabio; Raffaghello Lizzia; Bianchi Giovanna; Meloni Francesca; Salis Annalisa; Millo Enrico; Ferrone Soldano; Barnaba Vincenzo; Pistoia Vito
Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens.
Stem cells (Dayton, Ohio) 2008;26(5):1275-87.
2008: Belicha-Villanueva Alan; McEvoy Sarah; Cycon Kelly; Ferrone Soldano; Gollnick Sandra O; Bangia Naveen
Differential contribution of TAP and tapasin to HLA class I antigen expression.
Immunology 2008;124(1):112-20.
2008: Schwenkert Michael; Birkholz Katrin; Schwemmlein Michael; Kellner Christian; Kügler Markus; Peipp Matthias; Nettelbeck Dirk M; Schuler-Thurner Beatrice; Schaft Niels; Dörrie Jan; Ferrone Soldano; Kämpgen Eckhart; Fey Georg H
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells.
Melanoma research 2008;18(2):73-84.
2008: Mehta Akash M; Jordanova Ekaterina S; Kenter Gemma G; Ferrone Soldano; Fleuren Gert-Jan
Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
Cancer immunology, immunotherapy : CII 2008;57(2):197-206.
2007: Signorino Elena; Brusa Davide; Granata Riccarda; Malavasi Fabio; Ferrone Soldano; Matera Lina
Contribution of dendritic cells' FcgammaRI and FcgammaRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodies.
Cancer biology & therapy 2007;6(12):1932-7.
2007: Pistoia Vito; Morandi Fabio; Wang Xinhui; Ferrone Soldano
Soluble HLA-G: Are they clinically relevant?
Seminars in cancer biology 2007;17(6):469-79.
2007: Theurillat Jean-Philippe; Zürrer-Härdi Ursina; Varga Zsuzsanna; Storz Martina; Probst-Hensch Nicole M; Seifert Burkhardt; Fehr Mathias K; Fink Daniel; Ferrone Soldano; Pestalozzi Bernhard; Jungbluth Achim A; Chen Yao-Tseng; Jäger Dirk; Knuth Alexander; Moch Holger
NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy.
Cancer immunology, immunotherapy : CII 2007;56(11):1723-31.
2007: Ferrone Soldano; Whiteside Theresa L
Tumor microenvironment and immune escape.
Surgical oncology clinics of North America 2007;16(4):755-74, viii.
2007: Tsuda Naotake; Chang David Z; Mine Takashi; Efferson Clay; García-Sastre Adolfo; Wang Xinhui; Ferrone Soldano; Ioannides Constantin G
Taxol increases the amount and T cell activating ability of self-immune stimulatory multimolecular complexes found in ovarian cancer cells.
Cancer research 2007;67(17):8378-87.
2007: Ko Eric; Luo Wei; Peng Liaomin; Wang Xinhui; Ferrone Soldano
Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity.
Cancer research 2007;67(16):7875-84.
2007: Connolly Nancy; Riddler Sharon; Stanson Joanna; Gooding William; Rinaldo Charles R; Ferrone Soldano; Whiteside Theresa L
Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects.
AIDS (London, England) 2007;21(13):1683-92.
2007: Mehling Matthias; Simon Perikles; Mittelbronn Michel; Meyermann Richard; Ferrone Soldano; Weller Michael; Wiendl Heinz
WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?
Acta neuropathologica 2007;114(2):111-9.
2007: Morandi Fabio; Levreri Isabella; Bocca Paola; Galleni Barbara; Raffaghello Lizzia; Ferrone Soldano; Prigione Ignazia; Pistoia Vito
Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
Cancer research 2007;67(13):6433-41.
2007: Raffaghello Lizzia; Nozza Paolo; Morandi Fabio; Camoriano Marta; Wang Xinhui; Garrè Maria Luisa; Cama Armando; Basso Giuseppe; Ferrone Soldano; Gambini Claudio; Pistoia Vito
Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.
Cancer research 2007;67(11):5471-8.
2007: Vermeulen Christine F W; Jordanova Ekaterina S; ter Haar Natalja T; Kolkman-Uljee Sandra M; de Miranda Noel F; Ferrone Soldano; Peters Alexander A W; Fleuren Gert Jan
Expression and genetic analysis of transporter associated with antigen processing in cervical carcinoma.
Gynecologic oncology 2007;105(3):593-9.
2007: Ogino Takeshi; Moriai Shigetaka; Ishida Yoshiya; Ishii Hideyuki; Katayama Akihiro; Miyokawa Naoyuki; Harabuchi Yasuaki; Ferrone Soldano
Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinoma.
International journal of cancer. Journal international du cancer 2007;120(11):2401-10.
2007: Wang Wenjun; Edington Howard D; Rao Uma N M; Jukic Drazen M; Land Stephanie R; Ferrone Soldano; Kirkwood John M
Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(5):1523-31.
2007: Chang Chien-Chung; Ferrone Soldano
Immune selective pressure and HLA class I antigen defects in malignant lesions.
Cancer immunology, immunotherapy : CII 2007;56(2):227-36.
2007: Leys Charles M; Nomura Sachiyo; LaFleur Bonnie J; Ferrone Soldano; Kaminishi Michio; Montgomery Elizabeth; Goldenring James R
Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancer.
Surgery 2007;141(1):41-50.
2007: Oflazoglu Ezogelin; Elliott Mark; Takita Hiroshi; Ferrone Soldano; Henderson Robert A; Repasky Elizabeth A
Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model.
Journal of translational medicine 2007;5():29.
2007: Dierssen Jan Willem F; de Miranda Noel F C C; Ferrone Soldano; van Puijenbroek Marjo; Cornelisse Cees J; Fleuren Gert Jan; van Wezel Tom; Morreau Hans
HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression.
BMC cancer 2007;7():33.
2006: Almeciga Ingrid; Wang Zhigang Charles; Zúñiga Joaquin; Fernandez-Viña Marcelo; Clavijo Olga; Araujo Hugo; Romero Viviana; Henry John; Ferrone Soldano; Yunis Edmond J
Allorecognition of an HLA-A*01 aberrant allele by an HLA identical family member carrying the HLA-A*0101 allele.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(12):8643-9.
2006: Chang Chien-Chung; Ferrone Soldano
NK cell activating ligands on human malignant cells: molecular and functional defects and potential clinical relevance.
Seminars in cancer biology 2006;16(5):383-92.
2006: Sabbatini Paul; Dupont Jakob; Aghajanian Carol; Derosa Felicia; Poynor Elizabeth; Anderson Sybil; Hensley Martee; Livingston Phillip; Iasonos Alexia; Spriggs David; McGuire William; Reinartz Silke; Schneider Sally; Grande Cathy; Lele Shashikant; Rodabaugh Kerry; Kepner James; Ferrone Soldano; Odunsi Kunle
Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5503-10.
2006: Ogino Takeshi; Shigyo Hiroshi; Ishii Hideyuki; Katayama Akihiro; Miyokawa Naoyuki; Harabuchi Yasuaki; Ferrone Soldano
HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
Cancer research 2006;66(18):9281-9.
2006: Ramnath N; Tan D; Li Q; Hylander B L; Bogner P; Ryes L; Ferrone S
Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?
Cancer immunology, immunotherapy : CII 2006;55(8):891-9.
2006: Ferris Robert L; Whiteside Theresa L; Ferrone Soldano
Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(13):3890-5.
2006: Petti Carlotta; Molla Alessandra; Vegetti Claudia; Ferrone Soldano; Anichini Andrea; Sensi Marialuisa
Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity.
Cancer research 2006;66(13):6503-11.
2006: Chang Chien-Chung; Ogino Takeshi; Mullins David W; Oliver Janine L; Yamshchikov Galina V; Bandoh Nobuyuki; Slingluff Craig L; Ferrone Soldano
Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells.
The Journal of biological chemistry 2006;281(27):18763-73.
2006: Reynolds Sandra R; Vergilis Irene J; Szarek Michael; Ferrone Soldano; Bystryn Jean-Claude
Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: a potential marker of response to immunotherapy?
International journal of cancer. Journal international du cancer 2006;119(1):157-61.
2006: Anichini Andrea; Mortarini Roberta; Nonaka Daisuke; Molla Alessandra; Vegetti Claudia; Montaldi Elisabetta; Wang Xinhui; Ferrone Soldano
Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients.
Cancer research 2006;66(12):6405-11.
2006: Luo Wei; Ko Eric; Hsu Jeff Chi-feng; Wang Xinhui; Ferrone Soldano
Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(10):6046-54.
2006: Luo W; Wang X; Kageshita T; Wakasugi S; Karpf A R; Ferrone S
Regulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cells.
Oncogene 2006;25(20):2873-84.
2006: Slingluff Craig L; Engelhard Victor H; Ferrone Soldano
Peptide and dendritic cell vaccines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 2):2342s-2345s.
2006: López-Albaitero Andrés; Nayak Jayakar V; Ogino Takeshi; Machandia Avinash; Gooding William; DeLeo Albert B; Ferrone Soldano; Ferris Robert L
Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(6):3402-9.
2006: Peng Liaomin; Ko Eric; Luo Wei; Wang Xinhui; Shrikant Protul A; Ferrone Soldano
CD4-dependent potentiation of a high molecular weight-melanoma-associated antigen-specific CTL response elicited in HLA-A2/Kb transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(4):2307-15.
2006: Claus Jonathan A; Brady Michael T; Lee Jaewoo; Donohue Kathleen A; Sait Sheila N; Ferrone Soldano; Wetzler Meir
T-Cell activation by t(9;22) acute lymphoblastic leukemia-derived dendritic-like cells is associated with increased tapasin expression.
Cancer immunology, immunotherapy : CII 2006;55(2):160-5.
2006: Seliger Barbara; Ritz Ulrike; Ferrone Soldano
Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation.
International journal of cancer. Journal international du cancer 2006;118(1):129-38.
2006: Bangia Naveen; Ferrone Soldano
Antigen presentation machinery (APM) modulation and soluble HLA molecules in the tumor microenvironment: do they provide tumor cells with escape mechanisms from recognition by cytotoxic T lymphocytes?
Immunological investigations 2006;35(3-4):485-503.
2005: Facoetti Angelica; Nano Rosanna; Zelini Paola; Morbini Patrizia; Benericetti Eugenio; Ceroni Mauro; Campoli Michael; Ferrone Soldano
Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8304-11.
2005: Albers Andreas; Abe Koji; Hunt Jennifer; Wang Jun; Lopez-Albaitero Andres; Schaefer Carsten; Gooding William; Whiteside Theresa L; Ferrone Soldano; DeLeo Albert; Ferris Robert L
Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Cancer research 2005;65(23):11146-55.
2005: Chang Chien-Chung; Hernandez-Guzman Francisco G; Luo Wei; Wang Xinhui; Ferrone Soldano; Ghosh Debashis
Structural basis of antigen mimicry in a clinically relevant melanoma antigen system.
The Journal of biological chemistry 2005;280(50):41546-52.
2005: Rouas-Freiss Nathalie; Moreau Philippe; Ferrone Soldano; Carosella Edgardo D
HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
Cancer research 2005;65(22):10139-44.
2005: Sconocchia Giuseppe; Lau Michelle; Provenzano Maurizio; Rezvani Katayoun; Wongsena Wachanan; Fujiwara Hiroshi; Hensel Nancy; Melenhorst Jos; Li Jonming; Ferrone Soldano; Barrett A John
The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions.
Blood 2005;106(10):3666-72.
2005: Raffaghello Lizzia; Prigione Ignazia; Airoldi Irma; Camoriano Marta; Morandi Fabio; Bocca Paolo; Gambini Claudio; Ferrone Soldano; Pistoia Vito
Mechanisms of immune evasion of human neuroblastoma.
Cancer letters 2005;228(1-2):155-61.
2005: Vergilis Irene J; Szarek Michael; Ferrone Soldano; Reynolds Sandra R
Presence and prognostic significance of melanoma-associated antigens CYT-MAA and HMW-MAA in serum of patients with melanoma.
The Journal of investigative dermatology 2005;125(3):526-31.
2005: Tourkova Irina L; Shurin Galina V; Chatta Gurkamal S; Perez Lori; Finke James; Whiteside Theresa L; Ferrone Soldano; Shurin Michael R
Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(5):3045-52.
2005: Bandoh N; Ogino T; Cho H S; Hur S Y; Shen J; Wang X; Kato S; Miyokawa N; Harabuchi Y; Ferrone S
Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies.
Tissue antigens 2005;66(3):185-94.
2005: Wang Xinhui; Ko Eric C; Peng Liaomin; Gillies Stephen D; Ferrone Soldano
Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2.
Cancer research 2005;65(15):6976-83.
2005: Yan Wei Hua; Lin Ai Fen; Chang Chien Chung; Ferrone Soldano
Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine.
Cell research 2005;15(7):523-31.
2005: Kloor Matthias; Becker Christina; Benner Axel; Woerner Stefan M; Gebert Johannes; Ferrone Soldano; von Knebel Doeberitz Magnus
Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers.
Cancer research 2005;65(14):6418-24.
2005: Kawano Kouichiro; Ferrone Soldano; Ioannides Constantin G
Functional idiotopes: tumor antigen-directed expression of CD8+ T-cell epitopes nested in unique NH2-terminal VH sequence of antiidiotypic antibodies?
Cancer research 2005;65(14):6001-4.
2005: Raffaghello Lizzia; Prigione Ignazia; Bocca Paola; Morandi Fabio; Camoriano Marta; Gambini Claudio; Wang Xinhui; Ferrone Soldano; Pistoia Vito
Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications.
Oncogene 2005;24(29):4634-44.
2005: Luo Wei; Hsu Jeff Chi-feng; Tsao Chun-yen; Ko Eric; Wang Xinhui; Ferrone Soldano
Differential immunogenicity of two peptides isolated by high molecular weight-melanoma-associated antigen-specific monoclonal antibodies with different affinities.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(11):7104-10.
2005: Yamshchikov Galina V; Mullins David W; Chang Chien-Chung; Ogino Takeshi; Thompson Lee; Presley Jennifer; Galavotti Holly; Aquila William; Deacon Donna; Ross William; Patterson James W; Engelhard Victor H; Ferrone Soldano; Slingluff Craig L
Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(11):6863-71.
2005: Kageshita T; Ishihara T; Campoli M; Ferrone S
Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Tissue antigens 2005;65(5):419-28.
2005: Wang Xinhui; Campoli Michael; Cho Hyun Suk; Ogino Takeshi; Bandoh Nobuyuki; Shen Jijia; Hur Soo Young; Kageshita Toshiro; Ferrone Soldano
A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections.
Journal of immunological methods 2005;299(1-2):139-51.
2005: Bolesta Elizabeth; Kowalczyk Aleksandra; Wierzbicki Andrzej; Rotkiewicz Piotr; Bambach Barbara; Tsao Chun-Yen; Horwacik Irena; Kolinski Andrzej; Rokita Hanna; Brecher Martin; Wang Xinhui; Ferrone Soldano; Kozbor Danuta
DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
Cancer research 2005;65(8):3410-8.
2005: Meissner Markus; Reichert Torsten E; Kunkel Martin; Gooding William; Whiteside Theresa L; Ferrone Soldano; Seliger Barbara
Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(7):2552-60.
2005: Hafner Christine; Breiteneder Heimo; Ferrone Soldano; Thallinger Christiane; Wagner Stefan; Schmidt Wolfgang M; Jasinska Joanna; Kundi Michael; Wolff Klaus; Zielinski Christoph C; Scheiner Otto; Wiedermann Ursula; Pehamberger Hubert
Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody.
International journal of cancer. Journal international du cancer 2005;114(3):426-32.
2005: Chang Chien-Chung; Campoli Michael; Restifo Nicholas P; Wang Xinhui; Ferrone Soldano
Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(3):1462-71.
2005: Vitale Marco; Pelusi Giuseppe; Taroni Beatrice; Gobbi Giuliana; Micheloni Cristina; Rezzani Rita; Donato Francesco; Wang Xinhui; Ferrone Soldano
HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):67-72.
2005: Wagner Stefan; Hafner Christine; Allwardt Dorothee; Jasinska Joanna; Ferrone Soldano; Zielinski Christoph C; Scheiner Otto; Wiedermann Ursula; Pehamberger Hubert; Breiteneder Heimo
Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(2):976-82.
2005: Ferris Robert L; Hunt Jennifer L; Ferrone Soldano
Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.
Immunologic research 2005;33(2):113-33.
2005: Campoli Michael; Ferrone Soldano; Zea Arnold H; Rodriguez Paulo C; Ochoa Augusto C
Mechanisms of tumor evasion.
Cancer treatment and research 2005;123():61-88.
2005: Luo Wei; Hsu Jeff Chi-Feng; Kieber-Emmons Thomas; Wang Xinhui; Ferrone Soldano
Human tumor associated antigen mimicry by xenoantigens, anti-idiotypic antibodies and peptide mimics: implications for immunotherapy of malignant diseases.
Cancer chemotherapy and biological response modifiers 2005;22():769-87.
2005: Chang Chien-Chung; Campoli Michael; Ferrone Soldano
Classical and nonclassical HLA class I antigen and NK Cell-activating ligand changes in malignant cells: current challenges and future directions.
Advances in cancer research 2005;93():189-234.
2004: Chang Chien-Chung; Campoli Michael; Luo Wei; Zhao Wanzhou; Zaenker Kurt S; Ferrone Soldano
Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanisms.
Annals of the New York Academy of Sciences 2004;1028():340-50.
2004: Prigione Ignazia; Corrias Maria Valeria; Airoldi Irma; Raffaghello Lizzia; Morandi Fabio; Bocca Paola; Cocco Claudia; Ferrone Soldano; Pistoia Vito
Immunogenicity of human neuroblastoma.
Annals of the New York Academy of Sciences 2004;1028():69-80.
2004: Wang Xinhui; Campoli Michael; Ko Eric; Luo Wei; Ferrone Soldano
Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Journal of immunological methods 2004;294(1-2):23-35.
2004: Chang Chien-Chung; Campoli Michael; Ferrone Soldano
HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?
Current opinion in immunology 2004;16(5):644-50.
2004: Raffaghello Lizzia; Prigione Ignazia; Airoldi Irma; Camoriano Marta; Levreri Isabella; Gambini Claudio; Pende Daniela; Steinle Alexander; Ferrone Soldano; Pistoia Vito
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.
Neoplasia (New York, N.Y.) 2004;6(5):558-68.
2004: Ferrone Soldano
Immunotherapy dispenses with tumor antigens.
Nature biotechnology 2004;22(9):1096-8.
2004: Murray James L; Gillogly Michael; Kawano Kouichiro; Efferson Clay L; Lee Jeffrey E; Ross Merrick; Wang Xinhui; Ferrone Soldano; Ioannides Constantin G
Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
Cancer research 2004;64(15):5481-8.
2004: Whiteside Theresa L; Stanson Joanna; Shurin Michael R; Ferrone Soldano
Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(3):1526-34.
2004: Yang Jianbo; Price Matthew A; Neudauer Cheryl L; Wilson Christopher; Ferrone Soldano; Xia Hong; Iida Joji; Simpson Melanie A; McCarthy James B
Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms.
The Journal of cell biology 2004;165(6):881-91.
2004: Demanet Christian; Mulder Arend; Deneys Veronique; Worsham Maria J; Maes Piet; Claas Frans H; Ferrone Soldano
Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?
Blood 2004;103(8):3122-30.
2004: Campoli Michael; Ferrone Soldano
T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?
Expert review of vaccines 2004;3(2):171-87.
2004: Atkins Derek; Breuckmann Aldona; Schmahl Gerd E; Binner Priska; Ferrone Soldano; Krummenauer Frank; Störkel Stephan; Seliger Barbara
MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
International journal of cancer. Journal international du cancer 2004;109(2):265-73.
2004: Atkins Derek; Ferrone Soldano; Schmahl Gerd E; Störkel Stefan; Seliger Barbara
Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
The Journal of urology 2004;171(2 Pt 1):885-9.
2004: Campoli Michael; Chang Chien-Chung; Oldford Sharon A; Edgecombe Allison D; Drover Sheila; Ferrone Soldano
HLA antigen changes in malignant tumors of mammary epithelial origin: molecular mechanisms and clinical implications.
Breast disease 2004;20():105-25.
2004: Campoli Michael R; Chang Chien-Chung; Kageshita Toshiro; Wang Xinhui; McCarthy James B; Ferrone Soldano
Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance.
Critical reviews in immunology 2004;24(4):267-96.
2003: Marincola Francesco M; Ferrone Soldano
Immunotherapy of melanoma: the good news, the bad ones and what to do next.
Seminars in cancer biology 2003;13(6):387-9.
2003: Chang Chien-Chung; Campoli Michael; Ferrone Soldano
HLA class I defects in malignant lesions: what have we learned?
The Keio journal of medicine 2003;52(4):220-9.
2003: Ko Eric C; Wang Xinhui; Ferrone Soldano
Immunotherapy of malignant diseases. Challenges and strategies.
International archives of allergy and immunology 2003;132(4):294-309.
2003: Ogino T; Wang X; Kato S; Miyokawa N; Harabuchi Y; Ferrone S
Endoplasmic reticulum chaperone-specific monoclonal antibodies for flow cytometry and immunohistochemical staining.
Tissue antigens 2003;62(5):385-93.
2003: Chang Chien-Chung; Murphy Shawn P; Ferrone Soldano
Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms.
Human immunology 2003;64(11):1057-63.
2003: Chang Chien-Chung; Ferrone Soldano
HLA-G in melanoma: can the current controversies be solved?
Seminars in cancer biology 2003;13(5):361-9.
2003: Ogino Takeshi; Bandoh Nobuyuki; Hayashi Tatsuya; Miyokawa Naoyuki; Harabuchi Yasuaki; Ferrone Soldano
Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(11):4043-51.
2003: Perosa Federico; Luccarelli Grazia; Prete Marcella; Favoino Elvira; Ferrone Soldano; Dammacco Franco
Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(4):1918-26.
2003: Wang X; Liang B; Rebmann V; Lu J; Celis E; Kageshita T; Grosse-Wilde H; Ferrone S
Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2.
Tissue antigens 2003;62(2):139-48.
2003: Dissemond Joachim; Goette Petra; Moers Janet; Lindeke Anette; Goos Manfred; Ferrone Soldano; Wagner Stephan N
Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions: association with lack of spontaneous regression.
Melanoma research 2003;13(4):371-7.
2003: Ogino Takeshi; Wang Xinhui; Ferrone Soldano
Modified flow cytometry and cell-ELISA methodology to detect HLA class I antigen processing machinery components in cytoplasm and endoplasmic reticulum.
Journal of immunological methods 2003;278(1-2):33-44.
2003: Marincola Francesco M; Wang Ena; Herlyn Meenhard; Seliger Barbara; Ferrone Soldano
Tumors as elusive targets of T-cell-based active immunotherapy.
Trends in immunology 2003;24(6):335-42.
2003: Dissemond Joachim; Götte Petra; Mörs Janet; Lindeke Anette; Goos Manfred; Ferrone Soldano; Wagner Stephan N
Association of TAP1 downregulation in human primary melanoma lesions with lack of spontaneous regression.
Melanoma research 2003;13(3):253-8.
2003: Seliger Barbara; Atkins Derek; Bock Michaela; Ritz Ulrike; Ferrone Soldano; Huber Christoph; Störkel Stefan
Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1721-7.
2003: Weinman Eric C; Roche Patrick C; Kasperbauer Jan L; Cha Steve S; Sargent Dan J; Cheville John; Murphy Linda M; Chen Lieping; Wettstein Peter J; Gostout Bobbie; Ferrone Soldano; Strome Scott E
Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma.
Cancer 2003;97(9):2203-11.
2003: Wetzler M; McElwain B K; Stewart C C; Blumenson L; Mortazavi A; Ford L A; Slack J L; Barcos M; Ferrone S; Baer M R
HLA-DR antigen-negative acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(4):707-15.
2003: Yang Tianyu; McNally Beth A; Ferrone Soldano; Liu Yang; Zheng Pan
A single-nucleotide deletion leads to rapid degradation of TAP-1 mRNA in a melanoma cell line.
The Journal of biological chemistry 2003;278(17):15291-6.
2003: Seliger Barbara; Abken Hinrich; Ferrone Soldano
HLA-G and MIC expression in tumors and their role in anti-tumor immunity.
Trends in immunology 2003;24(2):82-7.
2003: Contini Paola; Ghio Massimo; Poggi Alessandro; Filaci Gilberto; Indiveri Francesco; Ferrone Soldano; Puppo Francesco
Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
European journal of immunology 2003;33(1):125-34.
2002: Campoli Michael; Chang Chien-Chung; Ferrone Soldano
HLA class I antigen loss, tumor immune escape and immune selection.
Vaccine 2002;20 Suppl 4():A40-5.
2002: Pende Daniela; Rivera Paola; Marcenaro Stefania; Chang Chien-Chung; Biassoni Roberto; Conte Romana; Kubin Marek; Cosman David; Ferrone Soldano; Moretta Lorenzo; Moretta Alessandro
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
Cancer research 2002;62(21):6178-86.
2002: Ferrone Soldano
Changes in serum ganglioside and antibody levels in soft tissue sarcoma: are they the cause or the effect of tumor progression?
Cancer journal (Sudbury, Mass.) 2002;8(5):369-70.
2002: Wang Zhigang C; Smith Anajane G; Yunis Edmond J; Selvakumar Annamalai; Ferrone Soldano; McKinney Susan; Lee Jar How; Fernandez-Vina Marcelo; Hansen John A
Molecular characterization of the HLA-Cw*0409N allele.
Human immunology 2002;63(4):295-300.
2002: Seliger Barbara; Cabrera Teresa; Garrido Federico; Ferrone Soldano
HLA class I antigen abnormalities and immune escape by malignant cells.
Seminars in cancer biology 2002;12(1):3-13.
2002: Rothenfusser Simon; Buchwald Armin; Kock Sylvia; Ferrone Soldano; Fisch Paul
Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytes.
Cellular immunology 2002;215(1):32-44.
2002: Noronha Elvyra J; Wang Xinhui; Ferrone Soldano
Isolation of human tumor-associated cell surface antigen-binding scFvs.
Methods in molecular biology (Clifton, N.J.) 2002;178():227-33.
2001: Seliger B; Ritz U; Abele R; Bock M; Tampé R; Sutter G; Drexler I; Huber C; Ferrone S
Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway.
Cancer research 2001;61(24):8647-50.
2001: Wetzler M; Baer M R; Stewart S J; Donohue K; Ford L; Stewart C C; Repasky E A; Ferrone S
HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(1):128-33.
2001: Wang X; Luo W; Foon K A; Ferrone S
Tumor associated antigen (TAA) mimicry and immunotherapy of malignant diseases from anti-idiotypic antibodies to peptide mimics.
Cancer chemotherapy and biological response modifiers 2001;19():309-26.
2000: Desai S A; Wang X; Noronha E J; Zhou Q; Rebmann V; Grosse-Wilde H; Moy F J; Powers R; Ferrone S
Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(6):3275-83.
2000: Kageshita T; Hamby C V; Hirai S; Kimura T; Ono T; Ferrone S
Alpha(v)beta3 expression on blood vessels and melanoma cells in primary lesions: differential association with tumor progression and clinical prognosis.
Cancer immunology, immunotherapy : CII 2000;49(6):314-8.
2000: Moy F J; Desai S A; Wang X; Noronha E J; Zhou Q; Ferrone S; Powers R
Analysis by NMR spectroscopy of the structural homology between the linear and the cyclic peptide recognized by anti-human leukocyte antigen class I monoclonal antibody TP25.99*.
The Journal of biological chemistry 2000;275(32):24679-85.
2000: Kageshita T; Hamby C V; Hirai S; Kimura T; Ono T; Ferrone S
Differential clinical significance of alpha(v)Beta(3) expression in primary lesions of acral lentiginous melanoma and of other melanoma histotypes.
International journal of cancer. Journal international du cancer 2000;89(2):153-9.
2000: Wang X; Luo W; Ferrone S
Immunotherapy of melanoma: peptide mimics of a human high molecular weight-melanoma associated antigen.
Medicina 2000;60 Suppl 2():48-50.
1999: Perosa F; Prete M; Luccarelli G; Favoino B; Ferrone S; Dammacco F
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype.
Human immunology 1999;60(11):1058-66.
1999: Perosa F; Luccarelli G; Prete M; Ferrone S; Dammacco F
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma.
British journal of haematology 1999;106(4):987-94.
1999: Wang Z; Marincola F M; Rivoltini L; Parmiani G; Ferrone S
Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells.
The Journal of experimental medicine 1999;190(2):205-15.
1999: Willers J; Lucchese A; Kanduc D; Ferrone S
Molecular mimicry of phage displayed peptides mimicking GD3 ganglioside.
Peptides 1999;20(9):1021-6.
1998: Hamby C V; Chinol M; Palestro C J; Manzo C; Ferrone S
Improved tumor targeting of rhenium-186-labeled anti-human high-m.w. melanoma-associated antigen monoclonal antibody 763.74 following purification with anti-idiotypic monoclonal antibody MK2-23.
International journal of cancer. Journal international du cancer 1998;78(4):486-90.
1998: Wang Z; Arienti F; Parmiani G; Ferrone S
Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells.
European journal of immunology 1998;28(9):2817-26.
1998: Noronha E J; Wang X; Desai S A; Kageshita T; Ferrone S
Limited diversity of human scFv fragments isolated by panning a synthetic phage-display scFv library with cultured human melanoma cells.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(6):2968-76.
1998: Hicklin D J; Wang Z; Arienti F; Rivoltini L; Parmiani G; Ferrone S
beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.
The Journal of clinical investigation 1998;101(12):2720-9.
1998: Chatterjee-Kishore M; Kishore R; Hicklin D J; Marincola F M; Ferrone S
Different requirements for signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 in the regulation of low molecular mass polypeptide 2 and transporter associated with antigen processing 1 gene expression.
The Journal of biological chemistry 1998;273(26):16177-83.
1998: Desai S A; Wang X; Noronha E J; Kageshita T; Ferrone S
Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Cancer research 1998;58(11):2417-25.
1998: Wang Z; Seliger B; Mike N; Momburg F; Knuth A; Ferrone S
Molecular analysis of the HLA-A2 antigen loss by melanoma cells SK-MEL-29.1.22 and SK-MEL-29.1.29.
Cancer research 1998;58(10):2149-57.
1998: Kishore R; Hicklin D J; Dellaratta D V; Golde U; Kageshita T; Seliger B; Ferrone S
Development and characterization of mouse anti-human LMP2, LMP7, TAP1 and TAP2 monoclonal antibodies.
Tissue antigens 1998;51(2):129-40.
1998: Perosa F; Luccarelli G; Neri M; De Pinto V; Ferrone S; Dammacco F
Evaluation of biotinylated cells as a source of antigens for characterization of their molecular profile.
International journal of clinical & laboratory research 1998;28(4):246-51.
1997: Fisch P; Meuer E; Pende D; Rothenfusser S; Viale O; Kock S; Ferrone S; Fradelizi D; Klein G; Moretta L; Rammensee H G; Boon T; Coulie P; van der Bruggen P
Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity.
European journal of immunology 1997;27(12):3368-79.
1997: Dellaratta D V; Hicklin D J; Kishore R; Kageshita T; Ferrone S
Characterization of rabbit antisera elicited with human LMP2- and LMP7-specific peptides and recombinant proteins.
Tissue antigens 1997;50(6):567-75.
1997: Hicklin D J; Dellaratta D V; Kishore R; Liang B; Kageshita T; Ferrone S
Beta2-microglobulin gene mutations in human melanoma cells: molecular characterization and implications for immune surveillance.
Melanoma research 1997;7 Suppl 2():S67-74.
1997: Hamby C V; Chinol M; Manzo C; Ferrone S
Purification by affinity chromatography with anti-idiotypic monoclonal antibodies of immunoreactive monoclonal antibodies following labeling with 188Re.
Hybridoma 1997;16(1):27-31.
1996: Hicklin D J; Kageshita T; Ferrone S
Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing.
Tissue antigens 1996;48(1):38-46.
1995: Mittelman A; Chen G Z; Wong G Y; Liu C; Hirai S; Ferrone S
Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(7):705-13.
1995: Iwasaki Y; Takabatake H; Monestier M; Ferrone S
Idiotypic diversity and variable region gene usage by mouse anti-HLA-DQ3 mAb.
Immunogenetics 1995;42(2):90-100.
1994: Iwasaki Y; Takabatake H; Shinji T; Monestier M; Ferrone S
Structural profile of idiotype, anti-idiotype and anti-anti-idiotype monoclonal antibodies in the HLA-DQ3 antigenic system.
European journal of immunology 1994;24(11):2874-81.
1994: May L T; Patel K; García D; Ndubuisi M I; Ferrone S; Mittelman A; Mackiewicz A; Sehgal P B
Sustained high levels of circulating chaperoned interleukin-6 after active specific cancer immunotherapy.
Blood 1994;84(6):1887-95.
1993: Ferrone S
Anti-idiotypes in melanoma.
Hybridoma 1993;12(5):509-14.
1993: Ferrone S; Kageshita T; Hirai S
Active specific immunotherapy of malignant melanoma with anti-idiotypic monoclonal antibodies.
The Journal of dermatology 1993;20(9):533-9.
1993: Wang Z; Hu X Z; Tatake R J; Yang S Y; Zeff R A; Ferrone S
Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells.
Cancer research 1993;53(18):4303-9.
1993: Chen Z J; Ferrone S
Comparison of the binding parameters to melanoma cells of antihuman high molecular weight-melanoma associated antigen (HMW-MAA) monoclonal antibodies (mAb) and syngeneic anti-anti-idiotypic (anti-anti-id) mAb.
Annals of the New York Academy of Sciences 1993;690():398-401.
1993: Ferrone S
Human tumor-associated antigen mimicry by anti-idiotypic antibodies. Immunogenicity and clinical trials in patients with solid tumors.
Annals of the New York Academy of Sciences 1993;690():214-24.
1993: Yang H; Chen Z J; Kageshita T; Yamada M; Ferrone S
Idiotypic cascade in the human high molecular weight melanoma-associated antigen system: fine specificity and idiotypic profile of anti-anti-idiotypic monoclonal antibodies.
European journal of immunology 1993;23(7):1671-7.
1993: Temponi M; Kekish U; Hamby C V; Nielsen H; Marboe C C; Ferrone S
Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues.
Journal of immunological methods 1993;161(2):239-56.
1993: Mariani S M; Armandola E A; Ferrone S
Preferential selection of a subset of anti-HLA-DR monoclonal antibodies by a syngeneic antiidiotypic monoclonal antibody.
Transplantation 1993;55(5):1176-81.
1993: Armandola E A; Mariani S M; Ferrone S
Serological and molecular characterization of mouse anti-idiotypic monoclonal antibodies elicited with the syngeneic anti-HLA-A2,28 monoclonal antibody CR11-351.
Molecular immunology 1993;30(3):287-300.
1993: Wang Z; Cao Y; Albino A P; Zeff R A; Houghton A; Ferrone S
Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA.
The Journal of clinical investigation 1993;91(2):684-92.
1993: Ferrone S; Chen Z J; Liu C C; Hirai S; Kageshita T; Mittelman A
Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibodies MK2-23. Experimental studies and clinical trials in patients with malignant melanoma.
Pharmacology & therapeutics 1993;57(2-3):259-90.
1993: Chen Z J; Yang H; Liu C C; Hirai S; Ferrone S
Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen.
Cancer research 1993;53(1):112-9.
1992: Mariani S M; Armandola E A; Ferrone S
Diversity of anti-HLA-DR antibodies elicited by distinct anti-idiotypic monoclonal antibodies recognizing idiotopes co-expressed by the immunizing monoclonal antibody.
Immunology 1992;77(4):597-603.
1992: Mariani S M; Armandola E A; Ferrone S
Heterogeneity in the anti-HLA-DR immune response elicited by the antiidiotypic monoclonal antibody F5-444. Analysis at the clonal level.
Transplantation 1992;54(6):1078-84.
1992: Armandola E A; Mariani S M; Zwickl M; Hardman N; Ferrone S
Molecular analysis of anti-idiotypic monoclonal antibodies in the HLA-DR antigenic system.
European journal of immunology 1992;22(11):2893-9.
1992: Tatake R J; Ferrone S; Zeff R A
The role of beta-2 microglobulin in temperature-sensitive and interferon-gamma-induced exocytosis of HLA class I molecules.
Transplantation 1992;54(3):395-403.
1992: Wang Z; Cao Y; D'Urso C M; Ferrone S
Differential susceptibility of cultured human melanoma cell lines to enhancement by retinoic acid of intercellular adhesion molecule 1 expression.
Cancer research 1992;52(17):4766-72.
1992: Temponi M; Gold A M; Ferrone S
Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Cancer research 1992;52(9):2497-503.
1991: Perosa F; Ferrone S; Dammacco F
Anti-idiotypic monoclonal antibodies reacting with idiotope on isolated-denatured chains of an anti-CD4 monoclonal antibody.
Immunology 1991;74(4):748-50.
1991: Temponi M; Fawwaz R A; Kekish U; Wang T S; Ferrone S
Improvement by affinity chromatography on antiidiotypic monoclonal antibodies (MAbs) of immunoreactivity and in vivo targeting of radiolabelled anti-HMW-MAA MAb TP61.5 in nude mice bearing human melanoma lesions.
International journal of cancer. Journal international du cancer 1991;49(4):624-30.
1991: Chen Z J; Yang H; Kageshita T; Ferrone S
Human high-molecular-weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody TK7-371.
Cancer research 1991;51(18):4790-7.
1991: Hayashibe K; Mishima Y; Ferrone S
Cloning and in vitro expression of a melanoma-associated antigen immunogenic in patients with melanoma.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(3):1098-104.
1991: Chen Z J; Yang H; Ferrone S
Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. Characterization of the immunogenicity in syngeneic hosts.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(3):1082-90.
1991: Mariani S M; Armandola E A; Ferrone S
Diversity in the fine specificity and idiotypic profile of mouse anti-HLA-DR monoclonal antibody elicited with the syngeneic anti-idiotypic monoclonal antibody F5-830.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(4):1322-30.
1991: Maio M; Altomonte M; Tatake R; Zeff R A; Ferrone S
Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
The Journal of clinical investigation 1991;88(1):282-9.
1991: Mariani S M; Armandola E A; Ferrone S
Diversity in the fine specificity of anti-HLA-DR monoclonal antibodies elicited with syngeneic antiidiotypic monoclonal antibodies.
Transplantation proceedings 1991;23(1 Pt 1):455-6.
1991: D'Urso C M; Wang Z G; Cao Y; Tatake R; Zeff R A; Ferrone S
Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.
The Journal of clinical investigation 1991;87(1):284-92.
1991: Wang Z G; Cao Y; D'Urso C; Houghton A N; Ferrone S
Molecular abnormalities in the expression of HLA class-I antigens by melanoma cells.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1991;6():101-5.
1991: Perosa F; Dannecker G; Ferrone S; Dammacco F
Immunochemical and functional characterization of anti-idiotypic antibodies to a mouse anti-CD4 monoclonal antibody.
International journal of clinical & laboratory research 1991;21(2):179-85.
1990: Shinji T; Ono R; Ferrone S
Fine specificity and idiotype diversity of a murine anti-HLA-DQw3 monoclonal antibody elicited with a syngeneic antiidiotypic monoclonal antibody.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(11):4291-7.
1990: Perosa F; Carbone R; Ferrone S; Dammacco F
Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate.
Journal of immunological methods 1990;128(1):9-16.
1990: Temponi M; Pupa S; Ferrone S
Purification of immunoreactive radiolabeled monoclonal antibodies with anti-idiotypic monoclonal antibodies.
Journal of immunological methods 1990;126(2):223-9.
1990: Natali P; Nicotra M R; Cavaliere R; Bigotti A; Romano G; Temponi M; Ferrone S
Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions.
Cancer research 1990;50(4):1271-8.
1989: Kusama M; Kageshita T; Chen Z J; Ferrone S
Characterization of syngeneic antiidiotypic monoclonal antibodies to murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(11):3844-52.
1989: Ono R; Sakaguchi K; Ferrone S
Modulation by antiidiotypic monoclonal antibodies of immune lysis mediated by anti-HLA monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(6):1921-9.
1989: Maio M; Gulwani B; Morgano A; Ferrone S
Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
International journal of cancer. Journal international du cancer 1989;44(3):554-9.
1989: Perosa F; Ferrone S
Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities.
The Journal of clinical investigation 1989;84(3):907-14.
1989: Maio M; Gulwani B; Langer J A; Kerbel R S; Duigou G J; Fisher P B; Ferrone S
Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
Cancer research 1989;49(11):2980-7.
1989: Natali P G; Bigotti A; Nicotra M R; Nardi R M; Delovu A; Segatto O; Ferrone S
Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
Cancer research 1989;49(5):1269-74.
1989: Temponi M; Kageshita T; Perosa F; Ono R; Okada H; Ferrone S
Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification.
Hybridoma 1989;8(1):85-95.
1989: Perosa F; Kageshita T; Ono R; Ferrone S
Serological methods to detect anti-idiotypic antibodies.
Methods in enzymology 1989;178():74-90.
1989: O'Connell M J; Chen Z J; Yang H; Yamada M; Massaro M; Mittelman A; Ferrone S
Active specific immunotherapy with antiidiotypic antibodies in patients with solid tumors.
Seminars in surgical oncology 1989;5(6):441-7.
1989: Natali P G; Fawwaz R; Ruiter D J; Bigotti A; Kageshita T; Temponi M; Ferrone S
Immunodiagnostic and immunotherapeutic applications of anti human melanoma associated antigen monoclonal antibodies.
Carcinogenesis; a comprehensive survey 1989;11():133-63.
1989: Maio M; Gulwani B; Tombesi S; Ferrone S
Modulation by cytokines of HLA antigens, intercellular adhesion molecule 1 and high molecular weight melanoma associated antigen expression and of immune lysis of clones derived from the melanoma cell line MeM 50-10.
Cancer immunology, immunotherapy : CII 1989;30(1):34-42.
1988: Perosa F; Ferrone S
Syngeneic antiidiotypic monoclonal antibodies to the murine anti-HLA-DR,DP monoclonal antibody CR11-462.
Human immunology 1988;23(4):255-69.
1988: Temponi M; Romano G; D'Urso C M; Wang Z; Kekish U; Ferrone S
Profile of intercellular adhesion molecule-1 (ICAM-1) synthesized by human melanoma cell lines.
Seminars in oncology 1988;15(6):595-607.
1988: Temponi M; Kekish U; Ferrone S
Immunoreactivity and affinity of murine IgG monoclonal antibodies purified by caprylic acid precipitation.
Journal of immunological methods 1988;115(1):151-2.
1988: Maio M; Gulwani B; Tombesi S; Langer J A; Duigou G J; Kerbel R S; Fisher P B; Ferrone S
Differential induction by immune interferon of the gene products of the HLA-D region on the melanoma cell line MeWo and its metastatic variant MeM 50-10.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(3):913-20.
1988: Ziai M R; Giordano A; Armandola E; Ferrone S
Purification by ammonium sulfate precipitation of bacteriophage lambda gt11 DNA for restriction analysis of cloned cDNA inserts.
Analytical biochemistry 1988;171(1):192-6.
1988: Sakaguchi K; Ono R; Tsujisaki M; Richiardi P; Carbonara A; Park M S; Tonai R; Terasaki P I; Ferrone S
Anti-HLA-B7,B27,Bw42,Bw54,Bw55,Bw56, Bw67,Bw73 monoclonal antibodies: specificity, idiotypes, and application for a double determinant immunoassay.
Human immunology 1988;21(3):193-207.
1988: Okada H; Ono R; Addonizio J C; Nagamatsu G R; Ferrone S
A solid-phase immunoassay to screen anti-HLA monoclonal antibodies.
Journal of immunological methods 1988;107(2):179-87.
1988: Tsujisaki M; Sakaguchi K; Igarashi M; Richiardi P; Perosa F; Ferrone S
Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1.
Transplantation 1988;45(3):632-9.
1987: Hamby C V; Liao S K; Kanamaru T; Ferrone S
Immunogenicity of human melanoma-associated antigens defined by murine monoclonal antibodies in allogeneic and xenogeneic hosts.
Cancer research 1987;47(20):5284-9.
1987: Gulwani B; Maio M; Imberti L; Melamede R J; Ferrone S
Immunosuppressive activity of T cell clones generated from human T cells stimulated with autologous TPHA cells.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(7):2130-6.
1987: Liao S K; Smith J W; Kwong P C; Natali P G; Kusama M; Hamby C V; Ferrone S
Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
Cancer research 1987;47(18):4835-41.
1987: Kusama M; Kageshita T; Tsujisaki M; Perosa F; Ferrone S
Syngeneic antiidiotypic antisera to murine antihuman high-molecular-weight melanoma-associated antigen monoclonal antibodies.
Cancer research 1987;47(16):4312-7.
1987: Ziai M R; Imberti L; Nicotra M R; Badaracco G; Segatto O; Natali P G; Ferrone S
Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Cancer research 1987;47(9):2474-80.
1987: Perosa F; Tsujisaki M; Ferrone S
Syngeneic anti-idiotypic antisera to murine monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(7):2202-7.
1986: Tsujisaki M; Kusama M; Sakaguchi K; Perosa F; Ferrone S
A sandwich assay to detect and characterize syngeneic anti-idiotypic antibodies to murine anti-HLA and tumor associated antigen monoclonal antibodies.
Journal of immunological methods 1986;95(1):47-55.
1986: Ziai M R; Imberti L; Kobayashi M; Perussia B; Trinchieri G; Ferrone S
Distinct functional domains on the recombinant human immune interferon molecule.
Cancer research 1986;46(12 Pt 1):6187-90.
1985: Ziai M R; Imberti L; Tongson A; Ferrone S
Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
Cancer research 1985;45(11 Pt 2):5877-82.
1985: Ziai M R; Imberti L; Ferrone S
An enzyme-linked double antibody immunoassay to measure murine immunoglobulins--its application to determine the specific activity of radiolabeled monoclonal antibodies.
Journal of immunological methods 1985;82(2):233-41.
1983: Natali P G; Segatto O; Zupi G; Cavaliere R; Giacomini P; Ferrone S
Isolation of viable melanoma cells from surgically removed lesions using dishes coated with monoclonal antibody to a high molecular weight melanoma associated antigen.
Journal of immunological methods 1983;62(3):337-46.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Soldano Ferrone

Research Profile (preview)

Chemicals & Drugs

Disorders

Living Beings

Physiology

Anatomy

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Soldano Ferrone (preview)

All Publications